CatalystPit

ISLMFINSILICO MEDICINE CAYMAN

RECENT NEWS
  • Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
INSILICO MEDICINE CAYMAN (ISLMF) · News · CatalystPit